ImmPACT Bio - Ownership and Business Overview

Life ScienceCompany

ImmPACT Bio Ownership

Who owns ImmPACT Bio?

ImmPACT Bio is owned by Lyell Immunopharma. It was acquired on October 24, 2024.

ImmPACT Bio Business Overview

Where is ImmPACT Bio headquartered?

ImmPACT Bio is headquartered in West Hills, California.

What sector is ImmPACT Bio in?

ImmPACT Bio is a life science company.

When was ImmPACT Bio founded?

ImmPACT Bio was founded in 2017.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.

ImmPACT Bio

ImmPACT Bio USA, Inc.

8501 Fallbrook Avenue, Suite 200,
West Hills, California 91304
United States,
(818) 857-4828
www.immpact-bio.com

ImmPACT Bio is a clinical-stage biotechnology company. ImmPACT’s lead program, IMPT-314, is a CD19/20-targeting chimeric antigen receptor (CAR) T-cell product candidate Lyell will continue developing for hematologic malignancies, including large B-cell lymphoma. IMPT-314 was designed to outperform the efficacy of approved CD19 CAR T-cell therapies via a dual-targeting CAR T-cell design and to improve CAR T-cell persistence by enriching for naïve and central memory T cells during manufacturing. ImmPACT Bio was founded in 2017 and is based in West Hills, California.


 Subscribe to unlock this and 207,502
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.